QTTB FY 2019 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-68.7% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$110M-6599.2% margin

Net Income

-$104M-6237.5% margin

EPS (Diluted)

$-44.41

Cash Flow

Operating Cash Flow

-$91M

Free Cash Flow

-$113M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$311M

Total Liabilities

$52M

Stockholders' Equity

$259M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$5M	-68.7%
Gross Profit	$2M	$5M	-68.7%
Operating Income	-$110M	-$60M	-83.5%
Net Income	-$104M	-$56M	-87.0%